Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβ peptides and F2-isoprostanes in the absence of detectable amyloid deposits

Jun Yao, Suzana S. Petanceska, Thomas J. Montine, David M. Holtzman, Stephen D. Schmidt, Carolyn A. Parker, Michael J. Callahan, William J. Lipinski, Charles L. Bisgaier, Brian A. Turner, Ralph A. Nixon, Ralph N. Martins, Charles Ouimet, Jonathan D. Smith, Peter Davies, Eugene Laska, Michelle E. Ehrlich, Lary C. Walker, Paul M. Mathews, Sam Gandy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Abstract

Aging and apolipoprotein E (APOE) isoform are among the most consistent risks for the development of Alzheimer's disease (AD). Metabolic factors that modulate risk have been elusive, though oxidative reactions and their by-products have been implicated in human AD and in transgenic mice with overt histological amyloidosis. We investigated the relationship between the levels of endogenous murine amyloid β(Aβ) peptides and the levels of a marker of oxidation in mice that never develop histological amyloidosis [i.e. APOE knockout (KO) mice with or without transgenic human APOE ε3 or human APOE ε4 alleles]. Aging-, gender-, and APOE-genotype-dependent changes were observed for endogenous mouse brain Aβ40 and Aβ42 peptides. Levels of the oxidized lipid F2-isoprostane (F2-isoPs) in the brains of the same animals as those used for the Aβ analyses revealed aging- and gender-dependent changes in APOE KO and in human APOE ε4 transgenic KO mice. Human APOE ε3 transgenic KO mice did not exhibit aging- or gender-dependent increases in F2-isoPs. In general, the changes in the levels of brain F2-isoPs in mice according to age, gender, and APOE genotype mirrored the changes in brain Aβ levels, which, in turn, paralleled known trends in the risk for human AD. These data indicate that there exists an aging-dependent, APOE-genotype-sensitive rise in murine brain Aβ levels despite the apparent inability of the peptide to form histologically detectable amyloid. Human APOE ε3, but not human APOE ε4, can apparently prevent the aging-dependent rise in murine brain Aβ levels, consistent with the relative risk for AD associated with these genotypes. The fidelity of the brain Aβ/F2-isoP relationship across multiple relevant variables supports the hypothesis that oxidized lipids play a role in AD pathogenesis, as has been suggested by recent evidence that F 2-isoPs can stimulate Aβ generation and aggregation.

Original languageEnglish
Pages (from-to)1011-1018
Number of pages8
JournalJournal of Neurochemistry
Volume90
Issue number4
DOIs
Publication statusPublished - Aug 2004
Externally publishedYes

Keywords

  • Aβ40 and Aβ42 peptides
  • APOE isoform
  • APOE knockout mice
  • Human APOE ε3 transgenic knockout mice (apoE3-expressing mice or apoE3 mice)
  • Human APOE ε4 transgenic knockout mice (apoE4-expressing mice or apoE4 mice)
  • Isoprostane
  • Oxidation

Fingerprint

Dive into the research topics of 'Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβ peptides and F2-isoprostanes in the absence of detectable amyloid deposits'. Together they form a unique fingerprint.

Cite this